Adding Brexit into the pandemic mix – clinical trials to continue...
Webinar - Free Q&A Session
Description
| Event | Webinar |
| Type | Virtual Event |
| Language | English |
| Date(s) | 23 Nov. 2020 |
| Time | 17:00 - 18:00 |
| Duration | 1 hour |
Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.
Adding Brexit into the pandemic mix – clinical trials to continue...
Agenda:
Updates on the MHRA guidelines and requirements post-BREXIT for clinical trials and drug safety
Perspective from a Subject Matter Expert - the EU QPPV
An opportunity to share questions and points to consider on BREXIT and the pandemic in parallel
Q&A, Discussions
Programme
| 17:00 |
Introduction to the Webinar Moderator(s): Mark Poulton, Poulton Quality Solutions |
|
Presentations
Louise Mawer, Mirabilitas Ltd
Sarah Hall, Mipsol Ltd
|
|
|
Q&A and Panel Discussion
Heather Sampson, University of Toronto
Hugh Davies, Oxford A Research Ethics Committee
|
|
| 18:00 |
End of the Webinar |